CanSino Biologics Inc. (FRA:CJH)
Germany · Delayed Price · Currency is EUR 4.400
-0.020 (-0.45%)
At close: Nov 27, 2025
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of €1.5 billion as of December 2, 2025. Its market cap has increased by 7.00% in one year.
Market Cap
1.50B
Enterprise Value
1.34B
Revenue
116.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.40
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 859.40M to 1.50B, an increase of 75.05%. That is a compound annual growth rate of 8.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 1.55B | 7.04% |
| Dec 31, 2024 | 1.44B | -0.20% |
| Dec 29, 2023 | 1.45B | -56.47% |
| Dec 30, 2022 | 3.32B | -55.43% |
| Dec 31, 2021 | 7.45B | -4.98% |
| Dec 31, 2020 | 7.85B | 422.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |